Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers June 25, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - June 25, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

6/25/17 - AOP Orphan and PharmaEssentia announce latest clinical results for Ropeginterferon alfa-2b in Polycythemia Vera from 3 abstracts presented at the 22nd Congress of the European Hematology Association (EHA) in Madrid
VIENNA and TAIPEI, Taiwan, June 25, 2017/ PRNewswire/ AOP Orphan Pharmaceuticals AG and PharmaEssentia Corporation announced latest results from 3 clinical studies on Ropeginterferon alfa-2b for patients with Polycythemia Vera presented at EHA 2017.. Ropeginterferon alfa-2b is a novel, long-acting, mono-pegylated proline interferon expected to be
6/25/17 - CytRx Announces Update on the Regulatory Pathway for Aldoxorubicin in Soft Tissue Sarcomas
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA CytRx Corporation a biopharmaceutical research and development company specializing in oncology, announced an update on the regulatory pathway for a New Drug Application submission for aldoxorubicin in soft tissue sarcomas. The Company plans to submit a rolling NDA under secti
6/25/17 - Dasatinib excels in worldwide phase II trial against pediatric CML
By a News Reporter-Staff News Editor at VerticalNews Science In 2002, the FDA approved the drug imatinib as a first-line therapy for adults with chronic myeloid leukemia caused by the fusion gene BCR-ABL, known as the Philadelphia chromosome. Now worldwide phase II clinical trial results presented at the American Society for Clinical Oncology Ann
6/25/17 - Drug firms' gifts linked to docs' choices; Physicians likely to favor remedy; of company doling out freebies
Aaron Mitchell, lead researcher for the study. "This raises the possibility that drug companies are able to influence prescribing practices through gifts to physicians," said Mitchell, a fellow with the University of North Carolina School of Medicine. Richard Schilsky, chief medical officer of the American Society of Clinical Oncology, was not sur
6/25/17 - IDEAS study spurs related research to impact dementia care
By a News Reporter-Staff News Editor at VerticalNews Health& Science Washington, DC and Chicago, The milestone Imaging Dementia- Evidence for Amyloid Scanning Study is working with government and academic researchers to launch three add-on studies to expand the impact of the core study where more than 18,000 people with cognitive decline but an u
6/25/17 - Imaging technique could be game changer for pharma
By a News Reporter-Staff News Editor at VerticalNews Health& Science In drug development, the body can be something of a black box. The step has gained ground in the drug industry, according to a story in Chemical& Engineering News, the weekly newsmagazine of the American Chemical Society. When Genentech, for example, was testing a drug candidate
6/25/17 - Investigational vaccine protected monkeys from HIV-like virus
By a News Reporter-Staff News Editor at VerticalNews Health DURHAM, N.C. Building on insights from an HIV vaccine regimen in humans that had partial success during a phase 3 clinical trial in Thailand, a Duke-led research team used a more-is-better approach in monkeys that appeared to improve vaccine protection from an HIV-like virus. "The vac
6/25/17 - Lenvatinib Demonstrates Positive Results vs Sorafenib Across All Endpoints in First-Line Phase 3 Non-inferiority Trial of Unresectable Hepatocellular...
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Eisai Inc. announced results from the REFLECT study, a Phase 3 trial evaluating lenvatinib, the company's multiple receptor tyrosine kinase inhibitor, for the first-line treatment of patients with unresectable hepatocellular carcinoma. These data will be presented in an oral..
6/25/17 - OPIOID CRISIS Are drug companies responsible? States file lawsuits against pharmaceutical firms to recoup costs
PORTSMOUTH- Much of the country, including New Hampshire and Maine, is struggling with an unprecedented crisis- people addicted to heroin and other synthetic opioids. Dan Tierney, spokesperson for the Ohio Attorney General's office, said the suit, filed May 31, is the second filed by a state against pharmaceutical companies. The lawsuit, filed in R
6/25/17 - Patent Issued for Enalapril Formulations (USPTO 9669008)
By a News Reporter-Staff News Editor at Heart Disease Weekly Silvergate Pharmaceuticals, Inc. has been issued patent number 9669008, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. This patent was filed on March 25, 2016 and was published online on June 6, 2017. According to the National Heart Blood and Lun
6/25/17 - PORTSMOUTH - Much of the country
PORTSMOUTH- Much of the country, including New Hampshire and Maine, is struggling with an unprecedented crisis- people addicted to heroin and other synthetic opioids. Dan Tierney, spokesperson for the Ohio Attorney General's office, said the suit, filed May 31, is the second filed by a state against pharmaceutical companies. The lawsuit, filed in R
6/25/17 - Rate Contract For The Supply Of Allopayhic Veterinary Medicines, Veterinary Feed Supplements, Chemicals, Cotton And Bandages And Ayurvedic Veterinary Medicines. [TendersInfo (India)]
Tenders are invited for Rate Contract for the Supply of Allopayhic Veterinary Medicines, Veterinary Feed Supplements, Chemicals, Cotton and Bandages and Ayurvedic Veterinary Medicines. Last date 25/07/2017 Major organization: HIMACHAL PRADESH CO-OPERATIVE MARKETING AND CONSUMERS FEDERATION LIMITED Address: BLOCK NO. 23. SDA Complex.
6/24/17 - ABPI React to News of Delay to Decision on Future Location of EMA
The Association of the British Pharmaceutical Industry issued the following statement by Executive Director, Research, Medicine& Innovation Virginia Acha following news that an announcement regarding the future location of the European Medicines Agency will be delayed until winter 2017:. "This is even more important given the fact that this crucia
6/24/17 - Alcyone Lifesciences, Lowell, Mass., Assigned Patent for Drug Delivery Systems
Alcyone Lifesciences, Lowell, Massachusetts, has been assigned a patent developed by four co-inventors for "drug delivery systems and methods." The co-inventors are P.J. Anand, Lowell, Massachusetts, Morgan Brophy, Somerville, Massachusetts, Deep Arjun Singh, Cambridge, Massachusetts, and Greg Eberl, Acton, Massachusetts. Written by Amal Ahmed; edi
6/24/17 - Amid Reports That President Trump Will Break Promise to Get Tough on Drug Pricing, Sens. Booker, Franken, Lawmakers Urge President Trump to Act on Solutions That Bring Down Prescription Drug Costs
With news reports indicating the White House is on the verge of issuing an executive order devoid of policies that would meaningfully reduce prescription drug prices, breaking yet another key promise to Americans, Sen. Cory Booker joined Sen. Al Franken and other Senate and House Democrats to urge President Donald Trump to act on solutions that tru
6/24/17 - As White House Prepares Gift to Big Pharma, Sen. Franken, Lawmakers Press President Trump to Get Behind Real Solutions to Bring Down Prescription Drug Costs
The office of Sen. Al Franken, D- Minn., issued the following news release:. As the White House prepares to gift the big pharmaceutical companies with an executive order that reportedly favors the industry over consumers, Sen. Al Franken led a wide group of Senate and House Democrats in pushing President Donald Trump to get behind real solutions to
6/24/17 - Astellas UK: Suspension from Membership of the ABPI to be Extended for 12 Months
Recent cases have shown wholly inadequate oversight and control at both Astellas UK and Astellas Pharma Europe and a' lamentable lack of concern for patient safety'. Astellas' original suspension in June 2016 related to an advisory board meeting and deception, including providing false information to the PMCPA by Astellas Pharma Europe.
6/24/17 - BARDA Gives Notice of Intent to Exercise First Contract Option to Further Fund MediWounds NexoBrid Development [T-break Tech (Middle East)]
MediWound Ltd., a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn and wound management, announces that it received from the U.S. Biomedical Advanced Research and Development Authority a written Notice of Intent to exercise an option to fund further research and development...
6/24/17 - Bipartisan Group of Senators Urge FDA Commissioner to Address Prescription Drug Costs
Commissioner Gottlieb recently stated that the FDA will take measures to curb anticompetitive abuses of its regulatory process for the approval of generic drugs. In their letter, the senators advocate for their legislative solution and ask Commissioner Gottlieb to detail the regulatory actions the FDA can and cannot take to address strategies that.
6/24/17 - Bristol-Myers Squibb Announces Availability of New ORENCIA abatacept Subcutaneous Administration Option for Patients 2 Years of Age and Older with...
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Bristol-Myers Squibb Company announced the availability of a new FDA- approved subcutaneous ORENCIA administration option for use in patients 2 years of age and older with moderately to severely active polyarticular Juvenile Idiopathic Arthritis. 1 The new prefilled syringe o
6/24/17 - Cara Receives Breakthrough Therapy Designation from FDA for I.V. CR845 for the Treatment of Chronic Kidney Disease-Associated Pruritus in Hemodialysis Patients [Tehran Times (Iran)]
-Cara Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to I.V.
6/24/17 - Citius Pharmaceuticals Announces Reverse Stock Split
By a News Reporter-Staff News Editor at Investment Weekly News Citius Pharmaceuticals, Inc., a specialty pharmaceutical company focused on critical care drug products, announced a reverse stock split of its outstanding common stock at a ratio of 1- for-15 effective at market open on Friday June 9, 2017. The reverse stock split will be effective w
6/24/17 - Collegium Pharmaceutical, Canton, Mass., Assigned Patent for Tamper-Resistant Pharmaceutical Compositions
Collegium Pharmaceutical, Canton, Massachusetts, has been assigned a patent developed by five co-inventors for "tamper-resistant pharmaceutical compositions of opioids and other drugs." The co-inventors are Roman Rariy, Philadelphia, Alison Fleming, Mansfield, Massachusetts, Jane C. Hirsh, Wellesley, Massachusetts, Said Saim, New Milford, Connectic
6/24/17 - Complete Nutrition Announces Dynamic Partnership with Innov8 Nutraceuticals
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Continuing to fulfill its mission of providing consumers with safe and effective fitness and wellness products, Complete Nutrition, a network of high-quality nutritional supplement retail stores, will exclusively feature the newly launched Innov8 product line in its 150+ loca
6/24/17 - Development of New Alzheimer's Drugs Lagging, Cleveland Clinic Report Finds
Alzheimer's disease drug development: pipeline 2017 is Cleveland Clinic's second annual review of Alzheimer's disease drug development and appears in the journal Alzheimer's& Dementia: Translational Research& Clinical Trials Interventions. "The purpose of presenting our annual findings is to help better understand the status of Alzheimer's disease
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415